Sign in

NCT06115265Recruiting

Ketogenic Diet and Diabetes Demonstration Project

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

KDDP is a prospective, 12-month pilot study comparing the effects of a novel lifestyle program, the Ketogenic Diet and Diabetes Demonstration Project (KDDP) to those of the National Diabetes Prevention Program (NDDP). KDDP is modeled to mimic the delivery platform of NDPP with the exception that participants in KDDP will be placed on a medically-supervised ketogenic diet, and participants in NDPP will be placed on a low fat diet. The purpose of this study is to compare the metabolic effects of the KDDP and the NDPP on glycemic control, lipid parameters, blood pressure, heart rate, weight, and coronary artery calcium scores in individuals with either type 2 diabetes or prediabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
17 Oct 2023
Start date
5 Sept 2023
Primary completion date
30 Oct 2026
Lead sponsor
University of New Mexico
NCT number
NCT06115265

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 5 Sept 2023 to the primary completion date, 30 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Known clinical cardiovascular disease (i.e. prior stroke, myocardial infarction, peripheral artery disease)

Other illness

  • History of type 1 diabetes
  • History of diabetic ketoacidosis
  • Advanced renal disease
  • Advanced liver disease
  • Terminal cancer

Lab values

  • LDL cholesterol ≥ 190 mg/dL
  • Triglycerides ≥ 500 mg/dL

Other

  • Individuals requiring insulin
  • Pregnancy

Who the study is looking for

  • Men and women ≥ 18 years old
  • BMI ≥27 kg/m2
  • Hemoglobin A1c ≥ 5.7% and/or fasting plasma glucose of 100-125 mg/dL

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of New Mexico
Coordinator of this site? Confirm its status
AlbuquerqueUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.